02257 聖諾醫藥－Ｂ
按盘价 
2.600 -0.200 (-7.143%) 盈利能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 资产回报率 (%) | -65.653% | -43.650% | -121.466% | -64.844% | -65.991% |
| 股东资金回报率 (%) | -97.028% | -52.934% | -363.658% | N/A | 31.652% |
| 资本运用回报率 (%) | -125.356% | -58.982% | -94.943% | -272.129% | -74.371% |
边际利润分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 毛利率 (%) | N/A | N/A | N/A | N/A | N/A |
| 未计利息、税项、折旧及摊销前利润率 (%) | N/A | N/A | N/A | N/A | N/A |
| 税前边际利润率 (%) | N/A | N/A | N/A | N/A | N/A |
| 纯利率 (%) | N/A | N/A | N/A | N/A | N/A |
变现能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 流动比率 (X) | 4.512 X | 8.241 X | 13.791 X | 1.117 X | 7.656 X |
| 速动比率 (X) | 4.512 X | 8.241 X | 13.791 X | 1.117 X | 7.656 X |
财务杠杆分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 总负债 / 总资产比率 (%) | 67.729% | 31.947% | 12.616% | 185.475% | 297.204% |
| 总债项 / 总资产比率 (%) | 11.671% | 6.561% | 2.925% | 2.615% | 7.997% |
| 净债项 / 总资产比率 (%) | -19.844% | -57.630% | -85.168% | -90.976% | -32.083% |
| 总债项 / 股东资金比率 (%) | 22.005% | 8.816% | 3.327% | N/A | N/A |
| 长期债项 / 股东资金比率 (%) | 19.072% | 7.381% | 2.691% | N/A | N/A |
| 净债项 / 股东资金比率 (%) | -37.414% | -77.433% | -96.852% | N/A | N/A |
| 净现金 / (债项) ($) | 1.50千万 | 9.45千万 | 2.05亿 | 1.00亿 | 7.96百万 |
| 每股净现金 / (债项) ($) | 0.172 | 1.074 | 2.327 | -- | -- |
| 总债项 / 资本运用比率 (%) | 14.090% | 7.185% | 3.137% | 17.911% | 9.012% |
| 利息盈利率 (X) | N/A | N/A | N/A | N/A | N/A |
营运效率分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 存货周转率日数 (日) | N/A | N/A | N/A | N/A | N/A |
| 应收贸易帐周转率日数 (日) | N/A | N/A | N/A | N/A | N/A |
| 应付贸易帐周转率日数 (日) | N/A | N/A | N/A | N/A | N/A |
| 备注： | 实时报价更新时间为22/11/2024 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | USD -41,065,000 |
| 增长率 | 8.183% |
| 每股盈利/(亏损) | USD -0.540 |
| 每股账面资产净值 ($) | USD 0.003 |